IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

KCK Ltd.

Q1 2023 Holdings

Filed 2023-05-05 | 3 holdings | $67.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Sight Sciences Inc(SGHT)COM82657M105$41.2M4,715,56261.2%
Neuropace Inc(NPCE)COM641288105$26.1M5,621,11138.7%
Aileron Therapeutics Inc(RNTX)COM NEW00887A204$27.7K22,3410.0%